Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Krisztian Homicsko

Showing results (1-10 of 54) with videos related to

Pageof 6
Sort By:
Current Opinion in Biotechnology|July 1, 2020
Organoid technology and applications in cancer immunotherapy and precision medicineKrisztian Homicsko
Anti-Cancer Drugs|December 22, 2010
Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answersKrisztian Homicsko, Dominik R Berthold
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian CancerAntonia Digklia, George Coukos, Krisztian Homicsko
Cancer Research|August 3, 2005
RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancerKrisztian Homicsko, Alexander Lukashev, Richard D Iggo
Chinese Journal of Cancer|January 4, 2014
Standards of care and novel approaches in the management of glioblastoma multiformeAndreas F Hottinger, Roger Stupp, Krisztian Homicsko
PET Clinics|May 10, 2016
PET Imaging in Glioma: The Neuro-Oncologist's ExpectationsAndreas F Hottinger, Marc Levivier, Laura Negretti, et al.
BMC Cancer|October 6, 2006
Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cellsChristophe Fuerer, Krisztian Homicsko, Alexander N Lukashev, et al.
Translational Gastroenterology and Hepatology|June 15, 2026
Enhancing future liver remnant hypertrophy: innovative preoperative strategies and emerging technologiesYanxian Ren, Heng Zhou, Krisztian Homicsko, et al.
Revue Medicale Suisse|May 29, 2020
[Locally advanced and metastatic melanoma : novelties]Alexandre Huber, Sofiya Latifyan, Asteria Nikolopoulou, et al.
Melanoma Research|September 5, 2014
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patientSolange Peters, Hasna Bouchaab, Stefan Zimmerman, et al.
Pageof 6

Showing results (1-10 of 54) with videos related to

Sort By:
Pageof 6
Current Opinion in Biotechnology|July 1, 2020
Organoid technology and applications in cancer immunotherapy and precision medicineKrisztian Homicsko
Anti-Cancer Drugs|December 22, 2010
Neoadjuvant and adjuvant strategies in renal cell carcinoma: more questions than answersKrisztian Homicsko, Dominik R Berthold
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|February 17, 2022
Trabectedin and Durvalumab Combination Is Feasible and Active in Relapsing Ovarian CancerAntonia Digklia, George Coukos, Krisztian Homicsko
Cancer Research|August 3, 2005
RAD001 (everolimus) improves the efficacy of replicating adenoviruses that target colon cancerKrisztian Homicsko, Alexander Lukashev, Richard D Iggo
Chinese Journal of Cancer|January 4, 2014
Standards of care and novel approaches in the management of glioblastoma multiformeAndreas F Hottinger, Roger Stupp, Krisztian Homicsko
PET Clinics|May 10, 2016
PET Imaging in Glioma: The Neuro-Oncologist's ExpectationsAndreas F Hottinger, Marc Levivier, Laura Negretti, et al.
BMC Cancer|October 6, 2006
Fusion of the BCL9 HD2 domain to E1A increases the cytopathic effect of an oncolytic adenovirus that targets colon cancer cellsChristophe Fuerer, Krisztian Homicsko, Alexander N Lukashev, et al.
Translational Gastroenterology and Hepatology|June 15, 2026
Enhancing future liver remnant hypertrophy: innovative preoperative strategies and emerging technologiesYanxian Ren, Heng Zhou, Krisztian Homicsko, et al.
Revue Medicale Suisse|May 29, 2020
[Locally advanced and metastatic melanoma : novelties]Alexandre Huber, Sofiya Latifyan, Asteria Nikolopoulou, et al.
Melanoma Research|September 5, 2014
Dramatic response of vemurafenib-induced cutaneous lesions upon switch to dual BRAF/MEK inhibition in a metastatic melanoma patientSolange Peters, Hasna Bouchaab, Stefan Zimmerman, et al.
Pageof 6